Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.794 USD | +4.96% | -0.75% | -1.98% |
Financials (USD)
Sales 2024 * | 55.47M | Sales 2025 * | 11.82M | Capitalization | 78.57M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -102M | EV / Sales 2024 * | -0.19 x |
Net cash position 2024 * | 89M | Net cash position 2025 * | - | EV / Sales 2025 * | 6.64 x |
P/E ratio 2024 * |
-2.56
x | P/E ratio 2025 * |
-1.26
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.47% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | +4.96% | ||
1 week | -0.75% | ||
1 month | -13.50% | ||
3 months | +3.10% | ||
6 months | +38.09% | ||
Current year | -1.98% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.794 | +5.63% | 333,979 |
24-05-30 | 0.7517 | +0.23% | 400,681 |
24-05-29 | 0.75 | -3.86% | 1,078,178 |
24-05-28 | 0.7801 | -2.49% | 737,774 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.98% | 78.57M | |
+40.73% | 739B | |
+31.73% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.42% | 240B | |
+9.11% | 210B | |
-5.44% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- HOOK Stock